AI assistant
CYTOKINETICS INC — Director's Dealing 2024
Dec 5, 2024
30870_dirs_2024-12-05_93cce0c9-515d-4321-bf79-56c4fdd346d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-12-03
Reporting Person: Blum Robert I (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-03 | Common Stock | A | 11529 | — | Acquired | 409207 | Direct |
| 2024-12-03 | Common Stock | F | 5843 | $51.51 | Disposed | 403364 | Direct |
| 2024-12-03 | Common Stock | A | 11530 | — | Acquired | 414894 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2083 | Indirect |
| Common Stock | 2083 | Indirect |
Footnotes
F1: Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units ("PSUs").
F2: Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs.
F3: Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting. These PSUs to vest in full December 3, 2025.
F4: Shares held by The Bridget Blum 2003 Irrevocable Trust.
F5: Shares held by The Brittany Blum 2003 Irrevocable Trust.